BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19602033)

  • 1. Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
    Lin A; Zhu CC; Chen HX; Chen BF; Zhang X; Zhang JG; Wang Q; Zhou WJ; Hu W; Yang HH; Xu HH; Yan WH
    J Cell Mol Med; 2010 Sep; 14(9):2318-29. PubMed ID: 19602033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma.
    Lin A; Chen HX; Zhu CC; Zhang X; Xu HH; Zhang JG; Wang Q; Zhou WJ; Yan WH
    J Cell Mol Med; 2010 Aug; 14(8):2162-71. PubMed ID: 19799650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.
    Schütt P; Schütt B; Switala M; Bauer S; Stamatis G; Opalka B; Eberhardt W; Schuler M; Horn PA; Rebmann V
    Hum Immunol; 2010 May; 71(5):489-95. PubMed ID: 20156510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.
    Yan WH; Liu D; Lu HY; Li YY; Zhang X; Lin A
    J Cell Mol Med; 2015 Apr; 19(4):778-85. PubMed ID: 25689063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
    Ben Amor A; Beauchemin K; Faucher MC; Hamzaoui A; Hamzaoui K; Roger M
    PLoS One; 2016; 11(8):e0161210. PubMed ID: 27517300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
    Chen HX; Lin A; Shen CJ; Zhen R; Chen BG; Zhang X; Cao FL; Zhang JG; Yan WH
    Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Lung Cancer; 2007 Nov; 58(2):267-74. PubMed ID: 17673327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
    Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
    Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
    Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
    Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HLA-G expression in renal cell carcinoma.
    Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
    Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.
    Lin A; Zhang X; Zhou WJ; Ruan YY; Xu DP; Wang Q; Yan WH
    Int J Cancer; 2011 Sep; 129(6):1382-90. PubMed ID: 21128238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
    Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
    Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer clones recognize specific soluble HLA class I molecules.
    Carbone E; Terrazzano G; Colonna M; Tuosto L; Piccolella E; Franksson L; Palazzolo G; Pérez-Villar JJ; Fontana S; Kärre K; Zappacosta S
    Eur J Immunol; 1996 Mar; 26(3):683-9. PubMed ID: 8605938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
    Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells.
    Le Maux A; Noël G; Birebent B; Grosset JM; Vu N; De Guibert S; Bernard M; Semana G; Amiot L
    Clin Exp Immunol; 2008 Apr; 152(1):50-6. PubMed ID: 18241225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma.
    Gan LH; Huang LF; Zhang X; Lin A; Xu DP; Wang Q; Wang TJ; Yan WH
    Hum Immunol; 2010 Sep; 71(9):899-904. PubMed ID: 20600448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble HLA-G molecules are increased in lymphoproliferative disorders.
    Sebti Y; Le Friec G; Pangault C; Gros F; Drénou B; Guilloux V; Bernard M; Lamy T; Fauchet R; Amiot L
    Hum Immunol; 2003 Nov; 64(11):1093-101. PubMed ID: 14602240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the plasma soluble human leukocyte antigen-G and interleukin-10 levels in childhood atopic asthma.
    Zheng XQ; Li CC; Xu DP; Lin A; Bao WG; Yang GS; Yan WH
    Hum Immunol; 2010 Oct; 71(10):982-7. PubMed ID: 20600443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble HLA-G in rheumatoid arthritis.
    Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
    Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.